Potential role of P2X7R in esophageal squamous cell carcinoma proliferation

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Purinergic Signalling Purinergic Signalling

• Publication date

  2017-04-11

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s11302-017-9559-2PMID 28397110PMCID PMC5563289
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Tumor Microenvironment in Esophageal Cancer

  2016cited by this paper
• Calcium Channels and Associated Receptors in Malignant Brain Tumor Therapy

  2016cited by this paper
• Accelerated tumor progression in mice lacking the ATP receptor P2X7.

  2015cited by this paper
• Epidemiology, Diagnosis, and Management of Esophageal Adenocarcinoma.

  2015cited by this paper
• The P2X7 receptor regulates cell survival, migration and invasion of pancreatic ductal adenocarcinoma cells

  2015cited by this paper
• P2X7 receptor as predictor gene for glioma radiosensitivity and median survival.

  2015cited by this paper
• Xerophilusin B induces cell cycle arrest and apoptosis in esophageal squamous cell carcinoma cells and does not cause toxicity in nude mice.

  2015cited by this paper
• Understanding the roles of the P2X7 receptor in solid tumour progression and therapeutic perspectives.

  2015cited by this paper
• Diet and esophageal disease

  2014cited by this paper
• The role of inflammation in cancer of the esophagus

  2014cited by this paper
• Silencing DACH1 Promotes Esophageal Cancer Growth by Inhibiting TGF-β Signaling

  2014cited by this paper
• Increased expression of HSP27 inhibits invasion and metastasis in human esophageal squamous cell carcinoma

  2014cited by this paper
• Nicotine upregulates microRNA-21 and promotes TGF-β-dependent epithelial-mesenchymal transition of esophageal cancer cells

  2014cited by this paper
• P2X7 Receptor Expression in Coexistence of Papillary Thyroid Carcinoma with Hashimoto's Thyroiditis

  2014cited by this paper
• Atorvastatin prevents ATP-driven invasiveness via P2X7 and EHBP1 signaling in PTEN-expressing prostate cancer cells.

  2014cited by this paper
• Paracrine Stimulation of P2X7 Receptor by ATP Activates a Proliferative Pathway in Ovarian Carcinoma Cells

  2014cited by this paper
• Inhibition of CD39 Enzymatic Function at the Surface of Tumor Cells Alleviates Their Immunosuppressive Activity

  2014cited by this paper
• P2X7 mRNA expression in non-small cell lung cancer: MicroRNA regulation and prognostic value

  2014cited by this paper
• Microenvironmental regulation of tumor progression and metastasis

  2013cited by this paper
• EPIDEMIOLOGY OF ESOPHAGEAL CANCER

  2013cited by this paper
• Epidemiology of esophageal cancer.

  2013cited by this paper
• P2X7R suppression promotes glioma growth through epidermal growth factor receptor signal pathway.

  2013cited by this paper
• Purinergic signalling and cancer

  2013cited by this paper
• Anthraquinone emodin inhibits human cancer cell invasiveness by antagonizing P2X7 receptors.

  2013cited by this paper
• GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer

  2013cited by this paper
• Purines, purinergic receptors, and cancer.

  2012cited by this paper
• P2X7 receptor activation leads to increased cell death in a radiosensitive human glioma cell line

  2012cited by this paper
• Autophagy-Dependent Anticancer Immune Responses Induced by Chemotherapeutic Agents in Mice

  2011cited by this paper
• P2X7 receptor activation enhances SK3 channels- and cystein cathepsin-dependent cancer cells invasiveness

  2011cited by this paper
• P2X7 receptor antagonism in the treatment of cancers

  2011cited by this paper
• Block of Purinergic P2X7R Inhibits Tumor Growth in a C6 Glioma Brain Tumor Animal Model

  2011cited by this paper
• [Diagnostics and treatment of esophageal cancers].

  2010cited by this paper
• Characterization of ATP‐induced cell death in the GL261 mouse glioma

  2010cited by this paper
• Trophic activity of a naturally occurring truncated isoform of the P2X7 receptor

  2010cited by this paper
• Differential ectonucleotidase expression in human bladder cancer cell lines.

  2010cited by this paper
• Extracellular adenosine triphosphate and adenosine in cancer

  2010cited by this paper
• Alcohol drinking, cigarette smoking, and the development of squamous cell carcinoma of the esophagus: epidemiology, clinical findings, and prevention

  2010cited by this paper
• Diagnostics and treatment of esophageal cancers

  2010cited by this paper
• gamma-Irradiation induces P2X(7) receptor-dependent ATP release from B16 melanoma cells.

  2010cited by this paper
• Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β–dependent adaptive immunity against tumors

  2009cited by this paper
• Chemotherapy induces ATP release from tumor cells

  2009cited by this paper
• P2X7: a growth-promoting receptor—implications for cancer

  2009cited by this paper
• Expression of purinergic receptors and modulation of P2X7 function by the inflammatory cytokine IFNgamma in human epithelial cells.

  2009cited by this paper
• Different properties of P2X7 receptor in hippocampal and cortical astrocytes

  2009cited by this paper
• Increased Level of Extracellular ATP at Tumor Sites: In Vivo Imaging with Plasma Membrane Luciferase

  2008cited by this paper
• Expression and function of the P2X(7) receptor in rat C6 glioma cells.

  2008cited by this paper
• Nucleotide- and nucleoside-converting ectoenzymes: Important modulators of purinergic signalling cascade.

  2008cited by this paper
• Gene-environment interaction: the role of SULT1A1 and CYP3A5 polymorphisms as risk modifiers for squamous cell carcinoma of the oesophagus.

  2006cited by this paper
• P2 receptors and cancer.

  2006cited by this paper
• The E-NTPDase family of ectonucleotidases: Structure function relationships and pathophysiological significance

  2006cited by this paper
• Cell migration and invasion assays.

  2005cited by this paper
• Identification and characterization of splice variants of the human P2X7 ATP channel.

  2005cited by this paper
• Human melanomas express functional P2X7 receptors

  2005cited by this paper
• P2X7 receptor-mediated apoptosis of human cervical epithelial cells.

  2004cited by this paper
• Immunocytochemical and pharmacological characterisation of P2-purinoceptor-mediated cell growth and death in PC-3 hormone refractory prostate cancer cells.

  2004cited by this paper
• Increased expression of apoptotic markers in melanoma

  2003cited by this paper
• Expression of purinergic receptors in non-melanoma skin cancers and their functional roles in A431 cells.

  2003cited by this paper
• Molecular physiology of P2X receptors.

  2002cited by this paper
• The human SH‐SY5Y neuroblastoma cell‐line expresses a functional P2X7 purinoceptor that modulates voltage‐dependent Ca2+ channel function

  2002cited by this paper
• Extracellular nucleotides inhibit growth of human oesophageal cancer cells via P2Y2-receptors

  2002cited by this paper
• Histologic Tumor Type Is an Independent Prognostic Parameter in Esophageal Cancer: Lessons From More Than 1,000 Consecutive Resections at a Single Center in the Western World

  2001cited by this paper
• Expression of a P2X7 Receptor by a Subpopulation of Human Osteoblasts

  2001cited by this paper
• Proteomic and functional evidence for a P2X7 receptor signalling complex

  2001cited by this paper
• Tumor-promoting functions of adenosine.

  2000cited by this paper
• Cytolytic P2X purinoceptors

  1998cited by this paper
• Receptors for purines and pyrimidines.

  1998cited by this paper
• A direct colorimetric assay for Ca2+ -stimulated ATPase activity.

  1986cited by this paper
• International Agency for Research on Cancer.

  1985cited by this paper

• Porphyromonas gingivalis promotes oral carcinogenesis through the NDK-ATP-P2X7 signal axis: An in vitro experimental study.

  2025cites this paper
• P2 receptors signaling in the esophagus: from inflammation to cancer

  2025cites this paper
• P2X7 receptors: a bibliometric review from 2002 to 2023

  2024cites this paper
• Role and Therapeutic Potential of P2X7 Receptor in Lung Cancer Progression.

  2024cites this paper
• Extracellular ATP/P2X7 receptor, a regulatory axis of migration in ovarian carcinoma-derived cells

  2024cites this paper
• Functional role of P2X7 purinergic receptor in cancer and cancer-related pain

  2024cites this paper
• ATP ion channel P2X7 receptor as a regulatory molecule in the progression of colorectal cancer.

  2023cites this paper
• A Nucleotide Metabolism-Related Gene Signature for Risk Stratification and Prognosis Prediction in Hepatocellular Carcinoma Based on an Integrated Transcriptomics and Metabolomics Approach

  2023cites this paper
• P2RX7 promotes osteosarcoma progression and glucose metabolism by enhancing c-Myc stabilization

  2023cites this paper
• AMP hydrolysis reduction in blood plasma of breast cancer elderly patients after different treatments

  2021cites this paper
• P2X7 receptor: a critical regulator and potential target for breast cancer

  2021cites this paper
• Autocrine and paracrine purinergic signaling in the most lethal types of cancer

  2021cites this paper
• EMP2 induces cytostasis and apoptosis via the TGFβ/SMAD/SP1 axis and recruitment of P2RX7 in urinary bladder urothelial carcinoma

  2021cites this paper
• To inhibit or to boost the ATP/P2RX7 pathway to fight cancer—that is the question

  2021cites this paper
• Effect of P2X7 receptor on tumorigenesis and its pharmacological properties.

  2020cites this paper
• Targeting the Tumor Microenvironment for a More Effective and Efficient Cancer Immunotherapy

  2020influential citation
• Immune landscape and a promising immune prognostic model associated with TP53 in early‐stage lung adenocarcinoma

  2020cites this paper
• P2Y2 receptor activation promotes esophageal cancer cells proliferation via ERK1/2 pathway.

  2020cites this paper
• P2X7 in Cancer: From Molecular Mechanisms to Therapeutics

  2020cites this paper
• Role of the P2X7 receptor in tumor-associated inflammation.

  2019cites this paper
• Alternative splicing of P2RX7 pre-messenger RNA in health and diseases: Myth or reality?

  2019cites this paper
• Purinergic P2X7 Receptor: A Cation Channel Sensitive to Tumor Microenvironment.

  2019cites this paper
• Ethanol upregulates the P2X7 purinergic receptor in human macrophages

  2018cites this paper
• The P2X7 Receptor in Inflammatory Diseases: Angel or Demon?

  2018cites this paper
• Multifaceted Effects of Extracellular Adenosine Triphosphate and Adenosine in the Tumor–Host Interaction and Therapeutic Perspectives

  2017cites this paper